#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4742447	Binding	Inhibition of CDK8 in human SW-620 cells assessed as reduction in IFNgamma-induced STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis	Homo sapiens	8	ALA4742387	cell-based format	Patent Bioactivity Data
2.	ALA4742448	Binding	Inhibition of haspin in synchronized human SW620 cells assessed as reduction in IFNgamma-induced H3T3 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis	Homo sapiens	8	ALA4742387	tissue-based format	Patent Bioactivity Data
3.	ALA4742449	Binding	Inhibition of CDK8 in human SW-620 cells assessed as reduction in STAT1 S727 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis	Homo sapiens	14	ALA4742387	cell-based format	Patent Bioactivity Data
4.	ALA4742450	Binding	Inhibition of haspin in human SW620 cells assessed as reduction in IFNgamma-induced H3T3 phosphorylation pre-incubated for 1 hr before IFNgamma stimulation for 3 hrs by Western blot analysis	Homo sapiens	9	ALA4742387	cell-based format	Patent Bioactivity Data
5.	ALA4742451	Functional	Antiproliferative activity against human MV4-11 cells assessed as reduction in cell proliferation by CellTiter-Glo luminescent cell viability assay	Homo sapiens	24	ALA4742387	cell-based format	Patent Bioactivity Data
6.	ALA4742452	Functional	Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell proliferation by CellTiter-Glo luminescent cell viability assay	Homo sapiens	24	ALA4742387	cell-based format	Patent Bioactivity Data
7.	ALA4742453	Functional	Antiproliferative activity against human SW-620 cells assessed as reduction in cell proliferation by CellTiter-Glo luminescent cell viability assay	Homo sapiens	27	ALA4742387	cell-based format	Patent Bioactivity Data
8.	ALA4742454	Functional	Antiproliferative activity against human MOLM-13 cells assessed as reduction in cell proliferation by CellTiter-Glo luminescent cell viability assay	Homo sapiens	22	ALA4742387	cell-based format	Patent Bioactivity Data
9.	ALA4742455	Functional	Synergistic antiproliferative activity against human SW-620 cells assessed as reduction in cell proliferation by measuring combination index in presence of taxol by MTT assay	Homo sapiens	1	ALA4742387	cell-based format	Patent Bioactivity Data
10.	ALA4742456	Functional	Synergistic antiproliferative activity against human SW-620 cells assessed as reduction in cell proliferation by measuring combination index in presence of ABT-751 by MTT assay	Homo sapiens	1	ALA4742387	cell-based format	Patent Bioactivity Data
11.	ALA4742457	Functional	Synergistic antiproliferative activity against human SW-620 cells assessed as reduction in cell proliferation by measuring combination index in presence of Ali-sertib by MTT assay	Homo sapiens	1	ALA4742387	cell-based format	Patent Bioactivity Data
12.	ALA4742458	Functional	Synergistic antiproliferative activity against human SW-620 cells assessed as reduction in cell proliferation by measuring combination index in presence of Elesclomol by MTT assay	Homo sapiens	1	ALA4742387	cell-based format	Patent Bioactivity Data
13.	ALA4742459	Functional	Synergistic antiproliferative activity against human SW-620 cells assessed as reduction in cell proliferation by measuring combination index in presence of Crizotinib by MTT assay	Homo sapiens	1	ALA4742387	cell-based format	Patent Bioactivity Data
14.	ALA4742460	Functional	Synergistic antiproliferative activity against human SW-620 cells assessed as reduction in cell proliferation by measuring combination index in presence of oxaliplatin by MTT assay	Homo sapiens	1	ALA4742387	cell-based format	Patent Bioactivity Data
15.	ALA4742461	Functional	Synergistic antiproliferative activity against human HCT-116 cells assessed as reduction in cell proliferation by measuring combination index in presence of taxol by MTT assay	Homo sapiens	1	ALA4742387	cell-based format	Patent Bioactivity Data
16.	ALA4742462	Functional	Synergistic antiproliferative activity against human HCT-116 cells assessed as reduction in cell proliferation by measuring combination index in presence of Ali-sertib by MTT assay	Homo sapiens	1	ALA4742387	cell-based format	Patent Bioactivity Data
17.	ALA4742463	Functional	Synergistic antiproliferative activity against human HCT-116 cells assessed as reduction in cell proliferation by measuring combination index in presence of crizotinib by MTT assay	Homo sapiens	1	ALA4742387	cell-based format	Patent Bioactivity Data
18.	ALA4742464	Functional	Synergistic antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell proliferation by measuring combination index in presence of Elesclomol by MTT assay	Homo sapiens	1	ALA4742387	cell-based format	Patent Bioactivity Data
19.	ALA4742465	Functional	Synergistic antiproliferative activity against human A549 cells assessed as reduction in cell proliferation by measuring combination index in presence of Elesclomol by MTT assay	Homo sapiens	1	ALA4742387	cell-based format	Patent Bioactivity Data
20.	ALA4742466	Functional	Synergistic antiproliferative activity against human SK-MEL19 cells assessed as reduction in cell proliferation by measuring combination index in presence of Crizotinib by MTT assay	Homo sapiens	1	ALA4742387	cell-based format	Patent Bioactivity Data